|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression multiple interactions |
EXP |
Quinpirole results in increased expression of ABCB1 protein Clozapine inhibits the reaction [Quinpirole results in increased expression of ABCB1 protein]; Spiperone inhibits the reaction [Quinpirole results in increased expression of ABCB1 protein] |
CTD |
PMID:9111066 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
multiple interactions increases activity increases expression |
EXP |
Clozapine inhibits the reaction [Quinpirole results in increased activity of ABCB1B promoter]; eticlopride inhibits the reaction [Quinpirole results in increased activity of ABCB1B promoter]; Spiperone inhibits the reaction [Quinpirole results in increased activity of ABCB1B promoter] Quinpirole results in increased expression of ABCB1B mRNA |
CTD |
PMID:9111066 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Adcy5 |
adenylate cyclase 5 |
multiple interactions |
ISO |
ADCY5 protein results in increased susceptibility to [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine co-treated with Quinpirole]; ADCY5 protein results in increased susceptibility to [Colforsin co-treated with Quinpirole]; ADCY5 protein results in increased susceptibility to [dihydrexidine co-treated with Quinpirole]; ADCY5 protein results in increased susceptibility to [Quinpirole co-treated with VIP protein] |
CTD |
PMID:12223546 |
|
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
|
|
G |
Cfl1 |
cofilin 1 |
multiple interactions increases phosphorylation |
ISO |
DRD2 protein affects the reaction [Quinpirole results in increased phosphorylation of CFL1 protein] |
CTD |
PMID:27717053 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions increases response to substance affects response to substance increases activity |
ISO EXP |
[Quinpirole binds to and results in increased activity of DRD2 protein alternative form] which results in decreased transport of Calcium; [Quinpirole binds to and results in increased activity of DRD2 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]; [Quinpirole co-treated with DRD2 protein alternative form] results in increased activity of RHOA protein; DRD2 protein promotes the reaction [Quinpirole results in decreased expression of POU5F1 mRNA]; epigallocatechin gallate inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]]; JB-788 inhibits the reaction [Quinpirole binds to and results in increased activity of DRD2 protein]; Quinpirole binds to and results in increased activity of DRD2 protein; Sulpiride inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein alternative form] which results in decreased transport of Calcium] DRD2 affects the susceptibility to [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole]; DRD2 protein affects the reaction [Quinpirole results in increased phosphorylation of CFL1 protein] DRD2 results in increased susceptibility to Quinpirole DRD2 protein affects the susceptibility to Quinpirole [Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine; cypermethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine]; decamethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine]; DRD2 protein affects the reaction [Quinpirole results in decreased transport of Barium]; estradiol 3-benzoate inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine]; Haloperidol inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine]; Mirtazapine inhibits the reaction [Quinpirole binds to DRD2 protein]; Nifedipine inhibits the reaction [DRD2 protein affects the reaction [Quinpirole results in decreased transport of Barium]]; Quinpirole binds to and results in increased activity of DRD2 protein; tautomycin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine] DRD2 protein results in increased susceptibility to Quinpirole Quinpirole results in increased activity of DRD2 protein |
CTD |
PMID:1724532 PMID:8032591 PMID:9547254 PMID:10936494 PMID:11124974 PMID:11790512 PMID:12071432 PMID:12523492 PMID:17958328 PMID:20580787 PMID:27717053 PMID:27920206 More...
|
|
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drd3 |
dopamine receptor D3 |
multiple interactions |
ISO EXP |
Quinpirole binds to and results in increased activity of DRD3 protein mirtazapine inhibits the reaction [Quinpirole binds to DRD3 protein] |
CTD |
PMID:10683862 PMID:12523492 |
|
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Drd4 |
dopamine receptor D4 |
affects binding |
EXP |
quinpirole binds to Drd4 protein |
RGD |
PMID:17314300 |
RGD:1625010 |
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
EXP |
Quinpirole inhibits the reaction [Reserpine results in increased expression of EGR1 mRNA] |
CTD |
PMID:9729266 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression increases expression multiple interactions |
EXP |
Quinpirole results in decreased expression of FOS mRNA; Quinpirole results in decreased expression of FOS protein Quinpirole results in increased expression of FOS protein 8-(3-chlorostyryl)caffeine promotes the reaction [Quinpirole inhibits the reaction [Reserpine results in increased expression of FOS protein]]; [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole] results in increased expression of FOS protein; [SK&F 81297 co-treated with Quinpirole] results in increased expression of FOS protein; Cocaine promotes the reaction [[SK&F 81297 co-treated with Quinpirole] results in increased expression of FOS protein]; Quinpirole inhibits the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased expression of FOS mRNA]; Quinpirole inhibits the reaction [Reserpine results in increased expression of FOS protein]; Quinpirole promotes the reaction [Reserpine results in increased expression of FOS protein]; Reserpine inhibits the reaction [[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole] results in increased expression of FOS protein]; Reserpine promotes the reaction [Quinpirole results in increased expression of FOS protein] |
CTD |
PMID:7845612 PMID:7914358 PMID:8102797 PMID:8577368 PMID:8864302 PMID:9751140 PMID:12122080 More...
|
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
multiple interactions |
ISO |
Quinpirole inhibits the reaction [Ovalbumin results in increased expression of GRIA1 protein modified form] |
CTD |
PMID:34624383 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
multiple interactions |
ISO |
Quinpirole inhibits the reaction [Ovalbumin results in increased expression of GRIA2 protein modified form] |
CTD |
PMID:34624383 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[SK&F 81297 co-treated with Quinpirole] results in increased expression of JUNB protein; Cocaine promotes the reaction [[SK&F 81297 co-treated with Quinpirole] results in increased expression of JUNB protein] |
CTD |
PMID:12122080 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
Quinpirole results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:27717053 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
Quinpirole results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:27717053 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases secretion |
ISO |
Quinpirole results in decreased secretion of MMP9 protein |
CTD |
PMID:27920206 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Npy |
neuropeptide Y |
multiple interactions |
ISO |
NPY protein results in decreased susceptibility to [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole] |
CTD |
PMID:12183048 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
increases activity |
ISO |
Quinpirole results in increased activity of ODC1 protein |
CTD |
PMID:10354516 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression multiple interactions |
ISO |
Quinpirole results in decreased expression of POU5F1 mRNA DRD2 protein promotes the reaction [Quinpirole results in decreased expression of POU5F1 mRNA] |
CTD |
PMID:27920206 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
multiple interactions |
ISO |
Quinpirole affects the reaction [Serotonin results in decreased phosphorylation of PPP1R1B protein]; Quinpirole affects the reaction [Serotonin results in increased phosphorylation of PPP1R1B protein] |
CTD |
PMID:11880652 |
|
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
|
|
G |
Rgs9 |
regulator of G-protein signaling 9 |
affects response to substance |
ISO |
RGS9 affects the susceptibility to Quinpirole |
CTD |
PMID:15728856 |
|
NCBI chr10:94,195,265...94,270,892
Ensembl chr10:94,197,054...94,270,892
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
ISO |
[Quinpirole co-treated with DRD2 protein alternative form] results in increased activity of RHOA protein |
CTD |
PMID:27717053 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Slc18a2 |
solute carrier family 18 member A2 |
affects response to substance |
ISO |
SLC18A2 protein affects the susceptibility to Quinpirole |
CTD |
PMID:12716422 |
|
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
increases expression affects localization |
EXP ISO |
Quinpirole results in increased expression of SLC6A3 mRNA Quinpirole affects the localization of SLC6A3 protein |
CTD |
PMID:20875051 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Tac1 |
tachykinin, precursor 1 |
multiple interactions |
EXP |
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Reserpine co-treated with Quinpirole] results in increased expression of TAC1 mRNA |
CTD |
PMID:9751140 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Trex1 |
three prime repair exonuclease 1 |
increases expression |
EXP |
Quinpirole results in increased expression of TREX1 mRNA |
CTD |
PMID:20298760 |
|
NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796
|
|
G |
Vip |
vasoactive intestinal peptide |
multiple interactions |
ISO |
ADCY5 protein results in increased susceptibility to [Quinpirole co-treated with VIP protein] |
CTD |
PMID:12223546 |
|
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
|
|